GL1X · GenesisL1 explorer

Research workbench

Quasi-atomic resolution model of bacteriophage PRD1 SUS1 mutant, obtained by combined cryo-EM and X-ray crystallography.

Analyse Quasi-atomic resolution model of bacteriophage PRD1 SUS1 mutant, obtained by… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1HB7
Type
protein
Length
4,452 residues
Chains
12
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bacteriophage PRD1 SUS1 mutant capsid
UniProt
P22535
Pockets
20 · best druggability 0.85

Structure

electron microscopy · 3 distinct chains · 15% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, D, G, JBacteriophage PRD1 SUS1 mutant capsidprotein37014% helix, 42% strandP22535
B, E, H, KBacteriophage PRD1 SUS1 mutant capsidprotein37215% helix, 42% strandP22535
C, F, I, LBacteriophage PRD1 SUS1 mutant capsidprotein37116% helix, 43% strandP22535

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111770.850.86114empty
210490.800.81104empty
310950.800.81114empty
41920.780.9327empty
56770.780.8366empty

Interfaces

22 interfaces between chains.

  • A–C · 1777 Ų buried · 33 hydrogen bonds · protein-protein
  • D–F · 1775 Ų buried · 33 hydrogen bonds · protein-protein
  • J–L · 1772 Ų buried · 33 hydrogen bonds · protein-protein
  • G–I · 1772 Ų buried · 33 hydrogen bonds · protein-protein
  • B–C · 1768 Ų buried · 36 hydrogen bonds · protein-protein

Compared structures

  • 1HB7 · quasi-atomic resolution model of bacteriophage PRD1 sus1 mutant, obtained by combined… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.